The role of biotransformation on the pharmacology of the monoamineoxidase inhibitor 5-oxo-N-(d-trans-2-phenylcyclopropyl)-1-2-pyrrolidone-carboxamide (EX-4883).
D000818:Animals; D001711:Biotransformation; D001921:Brain / Q000201:enzymology; D004305:Dose-Response Relationship, Drug; D006325:Heart Atria / Q000187:drug effects; D066298:In Vitro Techniques; D007928:Lethal Dose 50; D008099:Liver / Q000201:enzymology; D008297:Male; D051379:Mice; D008995:Monoamine Oxidase / Q000032:analysis; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology* / Q000633:toxicity; D009206:Myocardium / Q000201:enzymology; D011760:Pyrrolidinones / Q000494:pharmacology* / Q000633:toxicity; D051381:Rats; D014191:Tranylcypromine / Q000494:pharmacology
D008996:Monoamine Oxidase Inhibitors; D011760:Pyrrolidinones; D014191:Tranylcypromine; D008995:Monoamine Oxidase